Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human genetics implicates a BACH2-NRF2 axis in fetal haemoglobin activation. | Nature | 2026 | 42816612 | PubTator, text mining | PubMed |
| In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells. | bioRxiv | 2026 | 42779985 | PubTator, text mining | PubMed |
| CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia. | Hemoglobin | 2026 | 42755327 | PubTator, text mining | PubMed |
| Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches. | Biomed Pharmacother | 2026 | 42697041 | PubTator, text mining | PubMed |
| Acrylamide Exposure and Glycemic Dysregulation: A Population-Based Study. | Curr Diabetes Rev | 2026 | 42695284 | PubTator, text mining | PubMed |
| Molecular characterization of a rare norovirus GII.8[P8] strain detected during pediatric acute gastroenteritis surveillance in Harbin, China. | Virus Genes | 2026 | 42625105 | PubTator, text mining | PubMed |
| CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia. | N Engl J Med | 2026 | 42555951 | PubTator, text mining | PubMed |
| Epigenetic strategies for fetal hemoglobin induction in sickle cell disease. | Eur J Med Chem | 2026 | 42551134 | PubTator, text mining | PubMed |
| Genetic Analysis of Two Patients with Compound Thalassemia Presenting with Elevated HbF and Normal HbA2 Levels. | Hemoglobin | 2026 | 42509210 | PubTator, text mining | PubMed |
| Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer. | Mol Oncol | 2026 | 42462791 | PubTator, text mining | PubMed |
| Molecular Epidemiology of δβ-Thalassemia and Hereditary Persistence of Fetal Hemoglobin (HPFH) in the Quanzhou Childbearing-Age Population, China. | Hemoglobin | 2026 | 42443740 | PubTator, text mining | PubMed |
| Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the HBG1/2 promoters. | Mol Ther Nucleic Acids | 2026 | 42405279 | PubTator, text mining | PubMed |
| UCA1 lncRNA regulates γ-globin expression by modulating the miR-148b/BCL11A axis. | Life Sci Alliance | 2026 | 42373543 | PubTator, text mining | PubMed |
| Large-scale gastroenteritis outbreaks occurring in a university town of Guangzhou city during the global wave of the norovirus in China. | Virol J | 2026 | 42316287 | PubTator, text mining | PubMed |
| Hb F-SickKids (HBG2: C.308A > G): A Novel γ-Globin Variant Associated with Transient Neonatal Cyanosis. | Hemoglobin | 2026 | 42267386 | PubTator, text mining | PubMed |
| Daprodustat augments red cell and γ-globin production in models of sickle cell disease. | Blood Red Cells Iron | 2026 | 42266836 | PubTator, text mining | PubMed |
| Unmasking rare thalassemia variants through whole-exome sequencing in Huadu District, China: An observational study. | Medicine (Baltimore) | 2026 | 42216400 | PubTator, text mining | PubMed |
| A Prolonged Norovirus Infection and the Molecular Evolution of Human Norovirus Within-Host in a Child with Burkitt Lymphoma. | Viruses | 2026 | 42198741 | PubTator, text mining | PubMed |
| Modeling Therapeutic Targets: β-Globin Disorders and Beyond. | Adv Exp Med Biol | 2026 | 42178475 | PubTator, text mining | PubMed |
| Establishment of an immortalized erythroid model for Hb Bart's hydrops fetalis with homozygous α0-thalassemia Southeast Asian deletion. | Sci Rep | 2026 | 42162272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers